目的：检测肝细胞癌患者血清血管内皮生长因子与基质金属蛋白酶- 9含量并分析与临床分期的相关性。
Objective to detect the concentration of serum vascular endothelial growth factor and matrix metalloproteinase-9 in hepatocellular carcinoma and analyze their relation with the clinical stages.
目的通过检测肿瘤抑制基因产物pten蛋白在肝癌中的表达情况，探讨其作为一种评估肝细胞癌(HCC)生物学特征的分子标记的意义。
Objective to detect the expression of PTEN protein in hepatocellular carcinoma (HCC) to determine whether it can be used as a new molecular label for evaluation of biological characteristics of HCC.
目的：用SELDI蛋白质芯片技术检测HBV感染携带者与肝细胞癌（HCC）患者血清蛋白质谱的差异性表达，以发现HCC的早期诊断标志物。
Object Using SELDI protein chip technology to detect the different serum protein spectrum of HBV infected carriers and HCC patient , and to explore serum markers for diagnosis of HCC.
方法：采用SP免疫细胞化学方法，检测70例肝细胞癌组织中P 36的分布和表达。
Methods: SP immunocytochemical techniques were used to detect the distribution and expression of P36 in 70 cases of hepatocellular carcinoma.
方法应用免疫组织化学方法检测41例肝细胞肝癌及其癌旁组织中COX - 2和P -糖蛋白的表达情况。
Methods We detected the expressions of COX-2 and P-glucoprotein in the tissues inside and beside the tumor and normal tissues of 41 cases hepatocellular carcinoma in immunohistochemistry method.
RT-PCR在92%的纤维板层型肝细胞癌病例（24/26）中是检测成功的，并在所有成功纤维板层型肝细胞癌中发现了DNAJB1-PRKACA融合转录体，而其它类型的肿瘤均未发现。
RT-PCR was successful in 92% of tested fibrolamellar carcinoma cases (24/26) and the DNAJB1-PRKACA fusion transcript was found in all fibrolamellar carcinomas but not in other tumor types.
RT-PCR在92%的纤维板层型肝细胞癌病例（24/26）中是检测成功的，并在所有成功纤维板层型肝细胞癌中发现了DNAJB1-PRKACA融合转录体，而其它类型的肿瘤均未发现。
RT-PCR was successful in 92% of tested fibrolamellar carcinoma cases (24/26) and the DNAJB1-PRKACA fusion transcript was found in all fibrolamellar carcinomas but not in other tumor types.
应用推荐